(Q64912563)

30 June 2019

title

Candesartan cilexetil in combination with low-dose hydrochlorothiazide is effective in severe hypertension. (English)

1 reference

30 June 2019

1 reference

S Oparil

1

1 reference

30 June 2019

language of work or name

English

0 references

publication date

1 November 1999

1 reference

30 June 2019

American Journal of Cardiology

published in

1 reference

30 June 2019

volume

84

1 reference

30 June 2019

issue

10A

1 reference

30 June 2019

page(s)

35S-41S

1 reference

30 June 2019

Prevalence of Hypertension in the US Adult Population : Results From the Third National Health and Nutrition Examination Survey, 1988-1991

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900732-8

Effects of candesartan cilexetil in patients with systemic hypertension. Candesartan Cilexetil Study Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900732-8

Isolated systolic hypertension: an important cardiovascular risk factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900732-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900732-8

End-stage renal disease in African-American and white men. 16-year MRFIT findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900732-8

The impact of ethnicity on response to antihypertensive therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900732-8

10.1016/S0002-9149(99)00732-8

7 January 2021

Identifiers

DOI

1 reference

30 June 2019

PubMed ID

10588093

1 reference

30 June 2019